메뉴 건너뛰기
Library Notice
Institutional Access
If you certify, you can access the articles for free.
Check out your institutions.
ex)Hankuk University, Nuri Motors
Log in Register Help KOR
Subject

Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (PantogarⓇ) in Twenty-Nail Dystrophy
Recommendations
Search

논문 기본 정보

Type
Academic journal
Author
Journal
Korean Dermatological Association Annals of Dermatology Annals of Dermatology 제29권 제5호 KCI Accredited Journals SCOPUS
Published
2017.1
Pages
608 - 613 (6page)

Usage

cover
Therapeutic Efficacy of Combination Therapy Using Oral Cyclosporine with a Dietary Supplement (PantogarⓇ) in Twenty-Nail Dystrophy
Ask AI
Recommendations
Search

Abstract· Keywords

Report Errors
Background: Twenty-nail dystrophy (TND) is an acquired idiopathic disease characterized by dull, thin, lusterless, and fragile nails with fissuring, small regular pits, and excessive longitudinal ridging. Although various treatment modalities have been performed in order to treat TND, the effects of these treatments are controversial. Objective: To evaluate the effectiveness of oral cyclosporine in TND. Methods: A total of 38 patients with TND were treated with combination therapy using oral cyclosporine with a pantothenic acid complex-based dietary supplement (PantogarⓇ; Merz Pharmaceuticals GmbH, Germany), whereas 44 patients were treated with the pantothenic acid complex-based dietary supplement alone. The therapeutic efficacy in each group was retrospectively evaluated using medical records and clinical photographs. Results: The cyclosporine therapy group had significantly more patients whose improvement was rated as almost clear, marked, or moderate compared to the control group (p<0.001). While the mean CHATS (Color, Hyperkeratosis, Area, Thickness, Separation) score of the cyclosporine therapy group was decreased by 13.45 (from 30.95 to 17.5) after treatment, the mean CHATS score of the control group was only decreased by 8 (from 29.43 to 21.43, p<0.001). Moreover, greater Dermatology Life Quality Index changes after treatment were observed in the cyclosporine therapy group (p=0.085). Conclusion: Oral cyclosporine can be a valuable therapeutic option in patients with TND.

Contents

No content found

References (25)

Add References

Recommendations

It is an article recommended by DBpia according to the article similarity. Check out the related articles!

Related Authors

Recently viewed articles

Comments(0)

0

Write first comments.